162 related articles for article (PubMed ID: 33879188)
1. TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis.
Zhang Y; Ge X; Li Y; Zhang B; Wang P; Hao M; Gao P; Zhao Y; Sun T; Lu S; Ma W
Lipids Health Dis; 2021 Apr; 20(1):39. PubMed ID: 33879188
[TBL] [Abstract][Full Text] [Related]
2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
Cells; 2021 May; 10(6):. PubMed ID: 34072832
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression.
Li L; Fu J; Liu D; Sun J; Hou Y; Chen C; Shao J; Wang L; Wang X; Zhao R; Wang H; Andersen ME; Zhang Q; Xu Y; Pi J
Redox Biol; 2020 Feb; 30():101412. PubMed ID: 31901728
[TBL] [Abstract][Full Text] [Related]
6. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
Zhang X; Ji R; Sun H; Peng J; Ma X; Wang C; Fu Y; Bao L; Jin Y
Free Radic Res; 2018 Feb; 52(2):198-211. PubMed ID: 29400110
[TBL] [Abstract][Full Text] [Related]
7. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
[TBL] [Abstract][Full Text] [Related]
8. Twist1- and Twist2-haploinsufficiency results in reduced bone formation.
Huang Y; Meng T; Wang S; Zhang H; Mues G; Qin C; Feng JQ; D'Souza RN; Lu Y
PLoS One; 2014; 9(6):e99331. PubMed ID: 24971743
[TBL] [Abstract][Full Text] [Related]
9. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
11. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction
Zhou L; Li Q; Chen A; Liu N; Chen N; Chen X; Zhu L; Xia B; Gong Y; Chen X
FASEB J; 2019 Dec; 33(12):14254-14269. PubMed ID: 31648561
[TBL] [Abstract][Full Text] [Related]
12. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.
Ding J; Xu M; Du W; Fang ZQ; Xu H; Liu JJ; Song P; Xu C; Li ZW; Yue ZS; Ling YW; Duan JL; Tao KS; He F; Wang L
Int J Biol Sci; 2023; 19(6):1941-1954. PubMed ID: 37063432
[No Abstract] [Full Text] [Related]
14. TWIST1 and TWIST2 regulate glycogen storage and inflammatory genes in skeletal muscle.
Mudry JM; Massart J; Szekeres FL; Krook A
J Endocrinol; 2015 Mar; 224(3):303-13. PubMed ID: 25663706
[TBL] [Abstract][Full Text] [Related]
15. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
[TBL] [Abstract][Full Text] [Related]
16. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Lu K; Dong JL; Fan WJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
18. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
19. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
[TBL] [Abstract][Full Text] [Related]
20. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]